SynthesisBMC ophthalmology2025
Optical coherence tomography angiography measurements in tamoxifen associated retinopathy: a systematic review and meta-analysis.
Synthesis in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Structural and microvascular retinal changes in tamoxifen users assessed by optical coherence tomography and OCT angiography.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Early detection of tamoxifen-induced retinal injury: ellipsoid zone reflectivity as a sensitive structural marker.BMC ophthalmology · 2026Article
- Toremifene-induced bilateral macular crystalline deposits with cystic cavitation: a case report.Frontiers in medicine · 2026Article
- Retinal microvasculature and macular-choroidal thickness in oral contraceptive users: an OCTA and OCT comparative study.International journal of retina and vitreous · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the evidence for tamoxifen induced alterations of retina blood flow in macula region, using Optical Coherence Tomography Angiography (OCTA).
methodsA systematic review of PubMed, Google Scholar, Scopus, Web of Science, Cochrane, and Embase databases, including quality assessment of published studies, investigating the alterations of OCTA parameters in Tamoxifen Associated Retinopathy (TAR) was conducted. The outcomes of interest comprised alternations of Vascular Densities (VD) in Superficial and Deep capillary plexus (SCP and DCP) of fovea and parafovea, Telangiectatic vessels (TL), and the Right-Angled Vessels (RAVs).
resultsFrom the total of 680 articles obtained from the databases, the pool of papers was narrowed down to studies published until May 2024. Lastly, 5 studies were included. Our analysis demonstrated that 80% (95%CI: 63-97%) and 33% (95%CI: 23-44%) of patients on tamoxifen would manifest TL and RAVs in their OCTA, respectively. Tamoxifen patients had lower DCP-F and SCP-F vessel densities; however, only the drop in DCP-F vessel density was statistically significant (MD: -0.46, CI: -0.90 to - 0.01, p-value: 0.04).
conclusionOur results show that OCTA findings such as RAV and TL and vascular density DCP-F have been significantly altered compared to healthy controls. These findings demonstrate how OCTA can provide a non-invasive assessment of tamoxifen effects on the retinal microvasculature, potentially serving as a trustworthy biomarker for more accurate TAR identification and monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.